MedTrace Logo

Improving Asthma Treatment Using Inhaler Technology

NCT02977078 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-12-07

No results posted yet for this study

Summary

This study will use inhaler technology to observe and feedback overall patterns of medication use. We will look at whether this improves preventer inhaler use and reduces reliever inhaler overuse.

We will also assess whether inhaler technology is patient-friendly and cost effective, whether it helps with treatment decisions in asthma and whether it can help us to predict and prevent asthma attacks.

Conditions

Interventions

BEHAVIORAL

Active feedback on monitored inhaler use

Feedback given on inhaler use by research nurse/ doctor based on mobile application feedback

DEVICE

Inhaler casing

Monitors inhaler use

DEVICE

Mobile application

Mobile application software linked to inhaler casing

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Nottingham University Hospitals NHS Trust

    lead OTHER

Principal Investigators

  • Dominick Shaw · University of Nottingham

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02977078 on ClinicalTrials.gov